Immunoglobulin E as a Biomarker in Asthma

被引：17
|
作者：
Rath, Niharika [1 ]
Raje, Nikita [1 ]
Rosenwasser, Lanny [2 ]
机构：
[1] Univ Missouri, Childrens Mercy Hosp, Sch Med, Allergy Immunol, 2401 Gillham Rd, Kansas City, MO 64108 USA
[2] Univ Missouri, Sch Med, Allergy Immunol, 2411 Holmes St, Kansas City, MO 64108 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2018年 / 38卷 / 04期
关键词：
IgE; Asthma; Biomarker; Biotherapy; EXHALED NITRIC-OXIDE; TOTAL IGE; CELLS; EOSINOPHILS; REACTIVITY; PHENOTYPES;
D O I：
10.1016/j.iac.2018.06.007
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Asthma is a chronic disease that affects children and adults with significant morbidity and mortality. It is multifactorial, with genetic and environmental factors affecting the overall course of the disease. Both specific and total immunoglobulin (Ig)E can be used in specific phenotypes such as allergic asthma. Using IgE as a biomarker for asthma provides a target for management and treatment. Biotherapeutics continue to emerge as important advances in asthma treatment, and their effect on IgE and its biomarker role continue to be studied.
引用
收藏
页码：587 / +
页数：12
相关论文
共 50 条
  • [21] Selective adsorbent for the removal of immunoglobulin E in bronchial asthma
    Yu, Yaoting
    Zhang, Hongmei
    Wang, Weichao
    Wang, Shenqi
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2008, 36 (01): : 63 - 73
  • [22] Evaluation of serum immunoglobulin E levels in bronchial asthma
    Sandeep, Thirunavukkarasu
    Roopakala, Mysore Subrahmanyam
    Silvia, Chickballapur Rayappa Wilma Delphine
    Chandrashekara, Srikantaiah
    Rao, Mohan
    LUNG INDIA, 2010, 27 (03) : 138 - 140
  • [23] Anti-immunoglobulin E therapy with omalizumab for asthma
    Hendeles, Leslie
    Sorkness, Christine A.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (09) : 1397 - 1410
  • [24] NOD1 variation, immunoglobulin E and asthma
    Hysi, P
    Kabesch, M
    Moffatt, MF
    Schedel, M
    Carr, D
    Zhang, YM
    Boardman, B
    von Mutius, E
    Weiland, SK
    Leupold, W
    Fritzsch, C
    Klopp, N
    Musk, AW
    James, A
    Nunez, G
    Inohara, N
    Cookson, WOC
    HUMAN MOLECULAR GENETICS, 2005, 14 (07) : 935 - 941
  • [25] Relationships of total immunoglobulin e, allergic sensitisation and asthma severity in children with asthma
    Carroll, WD
    Child, F
    Fryer, AA
    Strange, RC
    Whyte, MK
    Primhak, RC
    Lenney, W
    THORAX, 2004, 59 (01) : 90 - 90
  • [26] Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
    Caruso, C.
    Ciasca, G.
    Baglivo, I.
    Di Santo, R.
    Gasbarrini, A.
    Firinu, D.
    Bagnasco, D.
    Passalacqua, G.
    Schiappoli, M.
    Caminati, M.
    Canonica, G. W.
    Heffler, E.
    Crimi, C.
    Intravaia, R.
    Basile, V.
    Marino, M.
    Colantuono, S.
    Del Giacco, S.
    ALLERGY, 2024, 79 (09) : 2414 - 2422
  • [27] Total immunoglobulin E in infant bronchiolitis and risk of developing asthma
    Shibata, Ryohei
    Fujiogi, Michimasa
    Nanishi, Makiko
    Ooka, Tadao
    Mansbach, Jonathan M.
    Teach, Stephen J.
    Hasegawa, Kohei
    Camargo, Carlos A., Jr.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2761 - +
  • [28] Targeted therapy in severe asthma today: focus on immunoglobulin E
    Pelaia, Girolamo
    Canonica, Giorgio Walter
    Matucci, Andrea
    Paolini, Rossella
    Triggiani, Massimo
    Paggiaro, Pierluigi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1979 - 1987
  • [29] Treatment of asthma with anti-immunoglobulin E monoclonal antibody
    Liu, AH
    ALLERGY AND ASTHMA PROCEEDINGS, 2006, 27 (02) : S24 - S28
  • [30] Asthma 2008: Targeting immunoglobulin E to achieve disease control
    Prenner, Bruce M.
    JOURNAL OF ASTHMA, 2008, 45 (06) : 429 - 436
12345